360° SearchNetwork Hot Spots Trends Time Series

Publication: Journal of Clinical Oncology

First reported Jun 18 2013 - Updated Jun 18 2013 - 1 reports

Unusual Ischemic Complication of Bevacizumab Treatment for Metastatic Colorectal Carcinoma [Diagnosis in Oncology]

Subscribe to the Journal - Subscribe to the print and/or online journal.Order Online - Purchase your subscription online. [regain access to your recent online order.]Renew Online - Renew your subscription online. [regain access to your recent online ... [Published Journal of Clinical Oncology - Jun 18 2013]

Entities: bevacizumab, carcinoma, colorectal

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Institute of Medicine

Critical Evaluation of Oncology Clinical Practice Guidelines [Health Services and Outcomes]

PurposeSignificant concerns exist regarding the content and reliability of oncology clinical practice guidelines (CPGs). The Institute of Medicine (IOM) report "Clinical Practice Guidelines We Can Trust" established standards for developing trustworthy ... [Published Journal of Clinical Oncology - Jun 11 2013]

Entities: Oncology, guidelines, colorectal, Institute of Medicine

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Vemurafenib-Induced Cardiac Tamponade: A Rare But Potentially Life-Threatening Complication [Diagnosis in Oncology]

Entities: Oncology

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Adrenocortical Carcinoma Is a Lynch Syndrome-Associated Cancer [Genetic Testing for Cancer]

PurposeAdrenocortical carcinoma (ACC) is an endocrine malignancy with a poor prognosis. The association of adult-onset ACC with inherited cancer predisposition syndromes is poorly understood. Our study sought to define the prevalence of Lynch syndrome ... [Published Journal of Clinical Oncology - Jun 11 2013]

Entities: Adrenocortical Carcinoma, Cancer, genetic testing, Patient, Tumor

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Patient Preference and Contraindications in Measuring Quality of Care: What Do Administrative Data Miss? [Health Services and Outcomes]

PurposePrior studies report that half of patients with lung cancer do not receive guideline-concordant care. With data from a national Veterans Health Administration (VHA) study on quality of care, we sought to determine what proportion of patients refused ... [Published Journal of Clinical Oncology - Jun 11 2013]

Entities: Patient, Lung Cancer, Adjuvant Chemotherapy, comorbidity, Standard Deviation

First reported Jun 08 2013 - Updated Jun 08 2013 - 1 reports

bendamustine

Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Hematologic Malignancies]

PurposeEffective and less aggressive therapies are required for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for or have undergone autologous stem-cell transplantation (ASCT). The present phase II study ... [Published Journal of Clinical Oncology - Jun 08 2013]

Entities: bendamustine, rituximab, B-Cell Lymphoma, Patient

First reported Jun 07 2013 - Updated Jun 07 2013 - 1 reports

Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer

Karim S. Fizazi, Celestia S. Higano, Joel B. Nelson, Martin Gleave, Kurt Miller, Thomas Morris, Faith E. Nathan, Stuart McIntosh, Kristine Pemberton, Judd W. MoulMay 10, 2013; 31:1740-1747Urologic Oncology ... [Published Journal of Clinical Oncology - Jun 07 2013]

Entities: Castrate-Resistant, Docetaxel, Metastatic, Phase III

First reported Jun 07 2013 - Updated Jun 07 2013 - 1 reports

Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non-Small-Cell Lung Cancer

Results Among 30 tumors, 311 genomic alterations were identified of which 63 were known recurrent (32 in primary tumor, 31 in metastasis) and 248 were nonrecurrent (likely passenger). TP53 mutations were the most frequently observed recurrent alterations ... [Published Journal of Clinical Oncology - Jun 07 2013]

Entities: primary tumor, Metastases, Lung Cancer, Patient

First reported Jun 07 2013 - Updated Jun 07 2013 - 1 reports

Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

Julien Mazières, Julie D. Milia, Hôpital Larrey, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse III (Paul Sabatier); Benoit Lepage, Centre Hospitalier Universitaire Toulouse; Isabelle Rouquette, Hôpital Rangueil, Centre Hospitalier ... [Published Journal of Clinical Oncology - Jun 07 2013]

Entities: Toulouse, Lung Cancer, Mutation, Strasbourg (France)

First reported Jun 07 2013 - Updated Jun 07 2013 - 1 reports

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors

Introduction A number of novel therapies are under investigation in relapsed or refractory peripheral T-cell lymphoma (PTCL); however, their relative impact on outcome is unknown. We examined the survival of patients with PTCL after relapse or progression ... [Published Journal of Clinical Oncology - Jun 07 2013]

Entities: T-Cell Lymphoma, Patient, Pakistan Telecommunication Company Limited

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Lymphocytic Vasculitis of the Uterus in a Patient With Melanoma Receiving Ipilimumab [Diagnosis in Oncology]

Entities: Ipilimumab, Uterus, Vasculitis, Lymphocyte

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy [Health Services and Outcomes]

PurposePatient-reported outcomes are increasingly used in routine outpatient cancer care to guide clinical decisions and enhance communication. Prior evidence suggests good patient compliance with reporting at scheduled clinic visits, but there is limited ... [Published Journal of Clinical Oncology - Jun 04 2013]

Entities: Chemotherapy, Patient, Toxic, Cancer, gynecologic

More Content

sort by: Date \| Relevance
Unusual Ischemic Complication of Bevacizumab Tr... [Published Journal of Clinical Oncology - Jun 18 2013]
Patient Preference and Contraindications in Mea... [Published Journal of Clinical Oncology - Jun 11 2013]
Critical Evaluation of Oncology Clinical Practi... [Published Journal of Clinical Oncology - Jun 11 2013]
Vemurafenib-Induced Cardiac Tamponade: A Rare B... [Published Journal of Clinical Oncology - Jun 11 2013]
Adrenocortical Carcinoma Is a Lynch Syndrome-As... [Published Journal of Clinical Oncology - Jun 11 2013]
Multicenter Phase II Study of Bendamustine Plus... [Published Journal of Clinical Oncology - Jun 08 2013]
Next-Generation Sequencing Reveals High Concord... [Published Journal of Clinical Oncology - Jun 07 2013]
Survival of Patients With Peripheral T-Cell Lym... [Published Journal of Clinical Oncology - Jun 07 2013]
Lung Cancer That Harbors an HER2 Mutation: Epid... [Published Journal of Clinical Oncology - Jun 07 2013]
Phase III, Randomized, Placebo-Controlled Study... [Published Journal of Clinical Oncology - Jun 07 2013]
Feasibility of Long-Term Patient Self-Reporting... [Published Journal of Clinical Oncology - Jun 04 2013]
Lymphocytic Vasculitis of the Uterus in a Patie... [Published Journal of Clinical Oncology - Jun 04 2013]
Multiple Myeloma Treatment Transformed: A Popul... [Published Journal of Clinical Oncology - May 30 2013]
Adjuvant MAGE-A3 Immunotherapy in Resected Non-... [Published Journal of Clinical Oncology - May 29 2013]
Erythema Nodosum-Like Panniculitis in Patients ... [Published Journal of Clinical Oncology - May 29 2013]
Randomized International Phase III Trial of ERC... [Published Journal of Clinical Oncology - May 21 2013]
International Myeloma Working Group Recommendat... [Published Journal of Clinical Oncology - May 21 2013]
Should a Woman Age 70 to 80 Years Receive Radia... [Published Journal of Clinical Oncology - May 21 2013]